Hepatic Medicine: Evidence and Research
| 短名 | HMER |
| Journal Impact | 2.46 |
| 国际分区 | GASTROENTEROLOGY & HEPATOLOGY(Q2) |
| ISSN | 1179-1535 |
| h-index |
Hepatic Medicine: Evidence and Research is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease Investigation and treatment of hepatic disease Pharmacology of drugs used for the treatment of hepatic disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered. As of 1st April 2019, Hepatic Medicine: Evidence and Research will no longer consider meta-analyses for publication.
期刊主页| 涉及主题 | 医学内科学生物遗传学胃肠病学病理化学生物化学免疫学外科肝硬化病毒学病毒内分泌学疾病肝病基因丙型肝炎病毒物理 |
| 出版信息 | 出版商: Informa UK Limited，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: ，原创研究文献占比: 58.33%，自引率:0.00%， Gold OA占比: 100.00% |
| 平均审稿周期 | 网友分享经验：16 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Highlighting Hepatopulmonary Syndrome: An Important Consideration in Decompensated Cirrhosis [Letter]
2024-9-1
Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes
2024-9-1
Retrospective Database Analysis of Liver-Related Clinical Events in Adult and Pediatric Patients with Alpha-1 Antitrypsin Deficiency in the United States
2024-7-1
Construction and Application of Patient-Participated Health Care Guidance Plan for Patients with Decompensated Hepatitis B Cirrhosis
2024-6-1
Advancing Hepatitis C Elimination in Africa: Insights from Egypt
2024-6-1
Synchronous Double Primary Tumors of Liver (Small Cell Neuroendocrine Carcinoma and Hepatocellular carcinoma): A Case Report
2024-4-1
Chimeric Livers: Interspecies Blastocyst Complementation and Xenotransplantation for End-Stage Liver Disease
2024-2-1
The Free Triiodothyronine, Gamma-Glutamyl Transpeptidase and Spontaneous Bacterial Peritonitis Index: A Novel Model for Predicting 1-Year Mortality in Patients with HBV-Related Hepatic Encephalopathy
2024-1-1
Disulfidptosis-Associated lncRNAs are Potential Biomarkers for Predicting Immune Response and Prognosis Within Individuals Diagnosed with Hepatocellular Carcinoma
2023-12-1
Medicinal Plants in Treating Hepatitis B Among Communities of Central Region of Ethiopia
2023-12-1
Analysis of SARS-CoV-2 Variant-Specific Serum Antibody Post-Vaccination Utilizing Immortalized Human Hepatocyte-Like Cells (HLC) to Assess Development of Immunity
2023-12-1
Epidemiology of Hepatitis B in Saudi Arabia from 2006 to 2021
2023-12-1
Confounders of Serum Phosphatidylethanol: Role of Red Blood Cell Turnover and Cirrhosis
2023-11-1
COVID-19 and the Liver: A Complex and Evolving Picture
2023-11-1
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention
2023-10-1
The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease
2023-10-1
Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?
2023-10-1
Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
2023-9-1
The Burden of Inappropriate Prescriptions and Predictors for Hospitalized Patients with Liver Cirrhosis in Ethiopia
2023-9-1
The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era
2023-9-1
Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
2023-8-1
Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case–Control Study
2023-7-1
The Accuracy of Ultrasound Controlled Attenuation Parameter in Diagnosing Hepatic Fat Content
2023-6-1
Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
2023-6-1
Thrombocytopenia (TCP), MELD Score, and Fibrosis Index (FI) Among Hospitalized Patients with Chronic Liver Disease (CLD) in Ma’abar City, Dhamar Governorate, Yemen: A Cross-Sectional Study
2023-4-1
Mucinous Cystic Neoplasms of the Liver: Epidemiology, Diagnosis, and Management
2023-3-1
Factors Associated with in-Hospital Mortality in Malagasy Patients with Acute Decompensation of Liver Cirrhosis: A Retrospective Cohort
2023-3-1
Medicinal Plants Used for the Management of Hepatitis Over the Past 15 Years in Ethiopia: A Systematic Review
2023-3-1
COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis
2023-3-1
COVID-19-Associated Liver Injury
2023-2-1
Perspectives on Sarcopenia as a Predictor for Outcomes in Pediatric Patients with Chronic Liver Disease
2022-10-1
Prevalence and Factors Associated with Hepatitis B Infection Among Outpatient Adults in South-Western Uganda
2022-10-1
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
2022-9-1
Histopathological Evaluation of Ethanolic Leaf Extract of Lippia adoensis on Liver, Kidney, and Biochemical Parameters in Swiss Albino Mice
2022-9-1
Undiagnosed Seroprevalence of Hepatitis B and C Virus Infections in the Community of Wolaita Zone, Southern Ethiopia
2022-8-1
Clinical, Laboratory and Bacterial Profile of Spontaneous Bacterial Peritonitis in Vietnamese Patients with Liver Cirrhosis
2022-7-1
Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus
2022-7-1
Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia
2022-5-1
Splenectomy Combined with Endoscopic Variceal Ligation (EVL) versus EVL Alone for Secondary Prophylaxis of Variceal Bleeding in Hepatosplenic Schistosomiasis: A Retrospective Case–Control Study
2022-5-1
Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus
2022-5-1
Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation
2022-4-1
Viral Hepatitis - The Road Traveled and the Journey Remaining
2022-3-1
Evaluation of the Effect of Hydromethanolic Seed Extract of Lepidium sativum L. (Fetto) on Deep-fried Palm Oil Diet Induced Nonalcoholic Fatty Liver Disease on Male Swiss Albino Mice
2022-2-1
Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Letter]
2021-12-1
The Prognostic Values of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-Hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study [Erratum]
2021-12-1
Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
2021-12-1
The Prognostic Values of Neutrophil-to-lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Baseline in Predicting the In-hospital Mortality in Black African Patients with Advanced Hepatocellular Carcinoma in Palliative Treatment: A Comparative Cohort Study
2021-12-1
Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
2021-12-1
Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
2021-11-1
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
2021-11-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远